Skip to search formSkip to main contentSkip to account menu

enomycin

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Peptides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Cloning of the EnomycinStructural Gene from Stveptomyces mauvecolor and Production of Recombinant Enomycin in Eschevichia coli
A genomic DNAlibrary from the enomycin (ENM) producer, Streptomyces mauvecolor, was screened for the ENMstructural gene (enm) by… 
1997
1997
Cloning of the enomycin structural gene from Streptomyces mauvecolor and production of recombinant enomycin in Escherichia coli.
A genomic DNA library from the enomycin (ENM) producer, Streptomyces mauvecolor, was screened for the ENM structural gene (enm… 
Review
1977
Review
1977
Effects of some proteins that inactivate the eukaryotic ribosome
1976
1976
Inhibition of the initial dipeptide synthesis of globin chains by the antibiotic enomycin in the reticulocyte lysate.
During inhibition of protein synthesis by the antibiotic enomycin at less than 5nm in the reticulocyte lysate system… 
1975
1975
[Action of antibiotic combinations with furacilin on the synthesis of proteins and nucleic acids in intact NAG-vibrio cells].
Furacillin in combination with such antibiotics as tetracycline, levomycetin or neomycin inhibited the synthesis of proteins in… 
1968
1968
Mode of action of enomycin, an antitumor antibiotic of high molecular weight. 3. On the weak inhibition of polyphenylalanine synthesis directed by polyuridylic acid.
1968
1968
Mode of action of enomycin, an antitumor antibiotic of high molecular weight. 3. On the weak inhibition of polyphenylalanine synthesis directed by polyuridylic acid.
1967
1967
Mode of action of enomycin, an antitumor antibiotic of high molecular weight. I. Inhibition of protein synthesis.
1967
1967
Mode of action of enomycin, an antitumor antibiotic of high molecular weight. II. Preferential binding of enomycin to mammalian ribosomes.
1963
1963
Studies on enomycin, a new antitumor substance
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)